Nemolizumab was well tolerated and provided lasting relief from itching and disease severity while improving quality of life in patients with prurigo nodularis (PN) over 68 weeks. Patients also ...

GSK has had another setback in its oncology business, after the FDA asked it to restrict use of its PARP inhibitor Zejula in ovarian, fallopian tube, or primary peritoneal cancer to patients with ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Researchers studied the efficacy and safety of ruxolitinib 1.5% cream for the treatment of adults with prurigo nodularis. Ruxolitinib 1.5% cream is associated with rapid and significant improvements ...

Background: Prurigo nodularis is a chronic pruritic dermatosis and narrowband-UVB (NB-UVB) phototherapy is considered an effective and safe treatment option in patients with multiple comorbidities.

Itchy skin (pruritus) without a rash may be caused by dry skin, allergies, bug bites, or an underlying medical condition. Health issues like liver disease, kidney disease, and thyroid disorders can ...

Prurigo nodularis is a skin condition that causes extremely itchy and symmetrical papulonodular lesions, usually on the extensor surfaces of the arms and legs. Its cause is still unknown, but it's ...